MARIA WUNDERLEY: Open Payments
NPI 1891312492 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,924 in 72 payments from 14 companies in 2025. Trend: 2023 $168 · 2024 $884 · 2025 $1,924
Food & beverage: $1,924
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $384 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $365 |
| Indivior Inc. | 11 | $340 |
| Otsuka America Pharmaceutical, Inc. | 14 | $304 |
| Alkermes, Inc. | 5 | $102 |
| Janssen Pharmaceuticals, Inc | 2 | $83 |
| Braeburn Inc. | 4 | $75 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Neurocrine BioSciences, Inc. | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
Products named: CAPLYTA, SUBLOCADE, VRAYLAR, REXULTI, ABILIFY MAINTENA, MAVYRET, VIVITROL, SPRAVATO.
Industry payments across PA — which companies pay providers there.
